Vimarsana
Biggest News Aggregation in the World

Accepted Author News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accepted Author. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accepted Author Today - Breaking & Trending Today

IL-23, IL-17 Inhibitors Associated with Lower Risk of Several Malignancies Compared to TNFi - Vimarsana News

IL-23, IL-17 Inhibitors Associated with Lower Risk of Several Malignancies Compared to TNFi

This new data should be taken into account before biologics prescriptions are made for patients with conditions such as psoriasis.

Patient-Oriented Scoring System for Atopic Dermatitis Shown to be Reliable, Effective - Vimarsana News

Patient-Oriented Scoring System for Atopic Dermatitis Shown to be Reliable, Effective

The use of this scoring system twice-per-week may help patients to better manage their mild-to-moderate atopic dermatitis.

Continuous Upadacitinib Treatment of Atopic Dermatitis Suggested to Ensure Maintenance of Skin Clearance - Vimarsana News

Continuous Upadacitinib Treatment of Atopic Dermatitis Suggested to Ensure Maintenance of Skin Clearance

In this latest research, the investigators noted that upadacitinib therapy may also be utilized as a treatment option for atopic dermatitis patients who experience a flare.

Air Pollution, Particulate Matter Associated with More Medical Visits for Atopic Dermatitis - Vimarsana News

Air Pollution, Particulate Matter Associated with More Medical Visits for Atopic Dermatitis

This study highlighted the strong effects of environmental factors on eczema, especially given the higher prevalence of the skin condition in industrialized countries.

Allergen, Immunotherapy Checklist Useful for Identifying Bias Effects on Adherence - Vimarsana News

Allergen, Immunotherapy Checklist Useful for Identifying Bias Effects on Adherence

A novel allergen and immunotherapy adherence and persistence checklist was developed to allow for more insight into adherence and to open this information to prescribing clinicians.